The stock of Teladoc Health Inc (NYSE:TDOC) last traded at $12.78, down -1.62% from the previous session.
TDOC stock price is now -11.50% away from the 50-day moving average and -32.76% away from the 200-day moving average. The market capitalization of the company currently stands at $2.17B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $22, Cantor Fitzgerald recently initiated with Overweight rating for Teladoc Health Inc (NYSE: TDOC). On February 26, 2024, Leerink Partners recently initiated its ‘Market Perform’ rating on the stock quoting a target price of $17, while ‘DA Davidson’ rates the stock as ‘Neutral’
In other news, Kornwasser Laizer, PRESIDENT, ENTERPRISE GROWTH sold 10,411 shares of the company’s stock on May 02 ’24. The stock was sold for $132,095 at an average price of $12.69. Upon completion of the transaction, the PRESIDENT, ENTERPRISE GROWTH now directly owns 86,070 shares in the company, valued at $1.1 million. An SEC document containing details of the transaction can be found on the SEC’s website. On May 02 ’24, CHIEF OPERATING OFFICER Waters Michael Willem sold 5,793 shares of the business’s stock. A total of $73,502 was realized by selling the stock at an average price of $12.69. This leaves the insider owning 64,881 shares of the company worth $0.83 million. A total of 1.09% of the company’s stock is owned by insiders.
During the past 12 months, Teladoc Health Inc has had a low of $12.53 and a high of $30.41. As of last week, the company has a debt-to-equity ratio of 0.69, a current ratio of 3.73, and a quick ratio of 3.65.
According to the Health Information Services Company, earnings per share came in at -0.4, beating analysts’ expectations of -0.41 by 0.01. This compares to -$0.42 EPS in the same period last year. The net profit margin was -8.90% and return on equity was -10.18% for TDOC. The company reported revenue of $646.13 million for the quarter, compared to $629.24 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 2.68 percent. For the current quarter, analysts expect TDOC to generate $651.18M in revenue.
